Neural Consult
PrivateLast Round
Seed
Jul 15, 2024
Total Funding Raised
$795,000
Company Overview
Neural Consult operates in AI, Data & Cloud Infrastructure and is based in the United States. Its latest recorded funding round was a Seed round in July 2024.
Neural Consult is an AI-powered medical education platform that provides personalized study tools, including clinical simulations, board-style question generation, and flashcard hubs for healthcare students and professionals.
Sector
AI, Data & Cloud Infrastructure
Verticals
Business Intelligence, NLP & Conversational AI, Workflow Automation, ML Platforms
Business Model
B2C
Customer Profile
Freemium, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neural Consult Comparables
Compare Neural Consult with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dendritic Health AI | 38% | |
| Mindgrasp | 34% | |
| StudyCards AI | 33% |
For institutional investors. Book with your work email.
Neural Consult Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 15, 2024 | ||||
| Grant | Apr 6, 2024 |
For institutional investors. Book with your work email.
Neural Consult Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dream Big Ventures | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2024
$770K raised in Seed round.
- Apr 6, 2024
$25K round from Dream Big Ventures
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asAug 17, 2026
Neural Consult receives the Best AI-Powered Medical Learning Platform 2026 - USA recognition from Global Health & Pharma (GHP) in the GHP Healthcare & Pharmaceutical Awards 2026 on Aug 17th '26.
For institutional investors. Book with your work email.
Neural Consult Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neural Consult's valuation, stock price, and market status.
Is Neural Consult a public or private company?
Neural Consult is a private company.
What is the current stock price of Neural Consult?
Neural Consult is a private company, so its shares have no public market price. Caplight tracks Neural Consult's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neural Consult worth (valuation)?
Valuation information for Neural Consult is not publicly available.
Can I buy Neural Consult stock?
Neural Consult shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neural Consult's last funding round?
Neural Consult's most recent funding round was Seed on July 15, 2024.
Who are the main investors in Neural Consult?
Key investors in Neural Consult include Dream Big Ventures.
Will Neural Consult IPO soon?
No public IPO plans have been announced for Neural Consult.
How can I track Neural Consult secondary market activity?
Caplight tracks bids, offers, and trades in Neural Consult's shares on secondary markets.